Unknown

Dataset Information

Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.


ABSTRACT: Fungal infections in humans are increasing worldwide and are currently mostly treated with a relative limited set of antifungals. Resistance to antifungals is increasing, for example, in Aspergillus fumigatus and Candida auris, and expected to increase for many medically relevant fungal species in the near future. We have developed and patented a set of cathelicidin-inspired antimicrobial peptides termed 'PepBiotics'. These peptides were initially selected for their bactericidal activity against clinically relevant Pseudomonas aeruginosa and Staphylococcus aureus isolates derived from patients with cystic fibrosis and are active against a wide range of bacteria (ESKAPE pathogens). We now report results from studies that were designed to investigate the antifungal activity of PepBiotics aga

SUBMITTER: van Eijk M 

PROVIDER: S-EPMC7657097 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature